Unlocking the Potential of [F-18]NAV-4694 in Alzheimer’s Diagnosis: A New Frontier in PET Imaging
[F-18]NAV-4694 shows promise in Alzheimer’s detection, with a strong safety profile and clear regulatory pathways.
Radiopharmaceuticals can be divided into radioactive molecules or radionuclides that facilitate diagnostic imaging and radiotherapy. Before being used in the clinical setting, all commercially produced radiopharmaceuticals must be approved by the US Food and Drug Administration (FDA).
Also, radiopharmaceuticals must possess various characteristics to be desirable for nuclear medicine applications. Radionuclide decay should be able to produce gamma emissions of suitable energy for diagnostic imaging. The ideal energy for a gamma camera is 100-200 keV, compared to 511 keV for positron emission tomography imaging.
Radiopharmaceuticals should not contain particle radiation, such as beta emissions, which can contribute to the patient’s radiation doses, even though beta emissions have therapeutic properties.
Furthermore, radionuclides should have an effective half-life for clinical applications. They should also be carrier-free and not contaminated with a stable radionuclide. If the specific activity changes, this can harm biodistribution and labelling efficiency.
Considering all the above, one of the best radionuclides for radiopharmaceuticals is technetium-99m, especially for gamma camera imaging. The radiopharmaceutical should rapidly localise in a specific part of the body according to the intended application. Background clearance should also be rapid to achieve reasonable target-to-background ratios.
Radiotherapy treatments involving the radionuclide attached to a vector (antibody) to deliver radioactivity to specific cells are called radioimmunotherapy.
For example, the radiopharmaceutical iodine-131 tositumomab, yttrium-90 ibritumomab and yttrium-90 epratuzumab are used to treat non-Hodgkin’s lymphoma.
Also, samarium-153 (Quadramet) is effective in relieving the pain of bone cancer and prostate and breast cancer. The most used radioisotope for treating bone metastasis in the US is samarium-153 EDTMP (lexidronam).
The pure beta emitter yttrium-90 is used to relieve the pain of arthritis in larger synovial joints. Other radiopharmaceuticals include Iofetamine (I-123 iodoamphetamine), used for non-invasive evaluation of local cerebral blood flow in cerebrovascular accidents, and dysprosium, used as an aggregated hydroxide for synovectomy (removal of synovial tissue surrounding a joint ) treatment of arthritis.
You are here:
home » radiopharmaceuticals »
[F-18]NAV-4694 shows promise in Alzheimer’s detection, with a strong safety profile and clear regulatory pathways.
Alzheimer’s disease stems from genetic mutations and lifestyle factors, leading to brain plaque accumulation and dementia.
Immuno-PET merges monoclonal antibodies with PET imaging, transforming precision oncology through enhanced tumor detection and monitoring.
Immuno-PET: Cancer Detection and Treatment in Nuclear Medicine Read Article »
Cyclotrons advance nuclear medicine by efficiently producing key radionuclides for diagnostics and treatment within hospital settings.
The Pivotal Role of Cyclotrons in Radionuclide Production Read Article »
Zevalin, combining monoclonal antibodies and radiation, offers hope against refractory B-cell non-Hodgkin’s lymphoma with targeted therapy.
Yttrium-90 chloride is pivotal in radioimmunotherapy, targeting cancer cells precisely while minimizing damage to surrounding tissues.
Yttrium-90 Chloride: A Vital Component in Radioimmunotherapy Read Article »
Xenon-133 is pivotal for imaging lungs and assessing brain flow, enhancing diagnoses in modern medicine.
Xenon-133: A Radiographic Cornerstone in Pulmonary and Cerebral Diagnostic Imaging Read Article »
Thallium-201 chloride is pivotal in myocardial perfusion imaging, diagnosing ischemic heart disease, and assessing myocardial viability.
Technetium-99m sulfur colloid provides critical diagnostics for liver, spleen, and bone marrow using targeted nuclear imaging.
The Role of Technetium-99m Sulfur Colloid in Diagnostic Imaging Read Article »
Technetium-99m UltraTag RBCs enhance blood pool imaging and precisely localize gastrointestinal bleeding in non-invasive diagnostic procedures.
Technetium-99m medronate is vital in nuclear medicine for precise bone imaging and detecting osteogenesis abnormalities.
Technetium-99m Medronate (MDP-25): Bone Imaging and Osteogenesis Evaluation Read Article »
Technetium-99m Mebrofenin is pivotal for hepatobiliary imaging, assessing liver function, gallbladder diseases, and biliary obstructions.
Strontium-89 chloride: a potent palliative for metastatic bone cancer-induced pain, through calcium-mimicking, localized beta radiation, ensuring effective, safer pain relief.
The Molybdenum-99 Generator crucially produces Technetium-99m for medical imaging, through radioactive decay, aiding numerous diagnostic procedures globally.
Molybdenum-99 Generator and its Impact on Medical Imaging Read Article »
Positrons, alpha particles, beta particles, and electron capture contribute to nuclear medicine, diagnostics, and diverse scientific applications.
Lutetium-177 Dotatate selectively binds to SSTRs on NET cells, delivering targeted radiation, minimizing collateral damage, and reducing side effects.
Lutetium-177 Dotatate: A Novel Therapeutic Approach in Neuroendocrine Tumours Read Article »
Iodine-131 sodium iodide, a radioactive isotope, is used in diagnosing and treating thyroid disorders and specific cancer therapies.
Iodine-131 Sodium Iodide: Thyroid Disorder Diagnosis and Treatment Read Article »
Iodine-131 Iobenguane (I-131 MIBG), a radiopharmaceutical agent, enables early diagnosis and targeted treatment of neuroendocrine tumours, improving patient outcomes.
Iodine-131 human serum albumin offers versatile diagnostic and therapeutic applications, despite limitations like radiation exposure and a short half-life.
Indium-111 pentetreotide excels in detecting and localising neuroendocrine tumors, monitoring treatment, and identifying therapy candidates.
Indium-111 Pentetreotide: A Valuable Tool in Nuclear Medicine Read Article »
Fluorine-18 Fluoroestradiol PET imaging enables early breast cancer detection, accurate staging, and treatment response monitoring, improving patient outcomes.
Fluorine-18 Fluoroestradiol: A Promising Tool for Breast Cancer Imaging Read Article »
Iodine-125 iothalamate, with high albumin affinity, ensures accurate GFR measurement, minimal radiation exposure, stability, and cost-effectiveness in diagnostics.
Iodine-125 Iothalamate: Diagnostic Imaging and Renal Function Read Article »
Iodine-125 Human Serum Albumin effectively measures blood volume, assesses vascular permeability, and evaluates protein-losing gastroenteropathy for accurate diagnosis.
Iodine-125 Human Serum Albumin: A Radiolabelled Diagnostic Agent Read Article »
Iodine-123 Sodium Iodide capsules aid in diagnosing thyroid disorders, providing vital insights into thyroid function and structure.
Iodine-123 Sodium Iodide Capsules: A Diagnostic Tool for Thyroid Disorders Read Article »
Iodine-123 Ioflupane known as DaTscan aids in diagnosing Parkinson’s disease by visualising dopamine transporters using SPECT imaging.
Iodine-123 iobenguane is vital for detecting, staging, and monitoring neuroendocrine tumours, guiding treatment, and offering prognostic insights.
Iodine-123 Iobenguane: Diagnosis and Evaluation of Neuroendocrine Tumours Read Article »
Indium-111 Pentetate enables tumour detection, infection, inflammation tracking, and cerebrospinal fluid leak identification.
Indium-111 Pentetate: Targeted Therapy in Oncology, Infection, and Inflammation Read Article »
Indium-111 oxyquinoline enables diverse cellular imaging, crucial for detecting infections, thrombosis, tumours, and advancing stem cell research.
Indium-111 Oxyquinoline: A Versatile Radiopharmaceutical Agent Read Article »
Indium-111 chloride effectively aids infection and inflammation imaging by labelling WBCs, enabling precise issue localisation and severity assessment.
Indium-111 Chloride: A Prominent Radiotracer in Nuclear Medicine Read Article »
Gallium-68 Gozetotide enhances PET imaging for oncology, targeting somatostatin receptors, and offering improved tumour detection and patient care.
Gallium-68 Gozetotide: A Radiopharmaceutical Agent for PET Imaging Read Article »
Gallium-68 DOTATOC revolutionises neuroendocrine tumor diagnosis, enhancing PET imaging accuracy, sensitivity, and management in the medical field.
Gallium-68 DOTATOC: PET Imaging of Neuroendocrine Tumour Read Article »